Pyrirnidinyl aryl urea derivatives being FGF inhibitors
US8759517B2 · kind B2 · utility
9Cited by
4References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 2012 |
| Grant date | Jun 24, 2014 |
| Priority date | — |
| Expiry date | Sep 21, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to heteroaryl aryl ureas of the formula IA,wherein the radicals and symbols have the meanings as defined herein, the use of such compounds in the treatment of protein kinase dependent diseases; to pharmaceutical preparations comprising said heteroaryl aryl ureas, to processes for the manufacture of such novel compounds and to methods of treatment comprising the use of such heteroaryl aryl ureas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.